“Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by blue light in the treatment of facial cutaneous squamous cell carcinoma in situ” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s483. doi:10.25251/skin.8.supp.483.